This methylation state can be used to distinguish IDH-mutant astrocytoma from other forms of diffusely infiltrating gliomas and other CNS neoplasms, and predict clinical outcomes [33, 34, 74, 108, 183, 227]. Here, IDH2 is linked to central nervous system neoplasm.